MIR4326

Across TCGA pan-cancer cohorts, MIR4326 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of MIR4326’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where MIR4326 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR4326 is over-expressed in tumor.

BRCA, STAD, and CHOL are the cancer types where MIR4326 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR4326 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	All	+0.389	.001	6	view →
STAD	All	II,III,IV	+0.501	.002	4	view →
CHOL	All	All	+1.864	<.001	3	view →
KIRC	Male	IV	+0.521	.012	3	view →
ESCA	Female	All	+1.423	.029	2	view →
HNSC	All	II,III,IV	+0.270	.035	2	view →
LUSC	Male	II,III,IV	+0.703	.039	1	view →
LIHC	All	All	+0.224	.025	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

MIR4326–BRCA

Open the BRCA breakdown →